Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31


Phase Ib/II study of hydroxychloroquine in combination with chemotherapy in patients with metastatic non-small cell lung cancer (NSCLC).

Malhotra J, Jabbour S, Orlick M, Riedlinger G, Guo Y, White E, Aisner J.

Cancer Treat Res Commun. 2019 Sep 5;21:100158. doi: 10.1016/j.ctarc.2019.100158. [Epub ahead of print]


Computer-Aided Laser Dissection: A Microdissection Workflow Leveraging Image Analysis Tools.

Hipp JD, Johann DJ, Chen Y, Madabhushi A, Monaco J, Cheng J, Rodriguez-Canales J, Stumpe MC, Riedlinger G, Rosenberg AZ, Hanson JC, Kunju LP, Emmert-Buck MR, Balis UJ, Tangrea MA.

J Pathol Inform. 2018 Dec 11;9:45. doi: 10.4103/jpi.jpi_60_18. eCollection 2018.


Association of JAK2-V617F Mutations Detected by Solid Tumor Sequencing With Coexistent Myeloproliferative Neoplasms.

Riedlinger G, Hadigol M, Khiabanian H, Ganesan S.

JAMA Oncol. 2019 Feb 1;5(2):265-267. doi: 10.1001/jamaoncol.2018.6286. No abstract available.


Endogenous retrovirus expression is associated with response to immune checkpoint blockade in clear cell renal cell carcinoma.

Panda A, de Cubas AA, Stein M, Riedlinger G, Kra J, Mayer T, Smith CC, Vincent BG, Serody JS, Beckermann KE, Ganesan S, Bhanot G, Rathmell WK.

JCI Insight. 2018 Aug 23;3(16). pii: 121522. doi: 10.1172/jci.insight.121522. eCollection 2018 Aug 23.


Detection of clonal hematopoiesis of indeterminate potential in clinical sequencing of solid tumor specimens.

Severson EA, Riedlinger GM, Connelly CF, Vergilio JA, Goldfinger M, Ramkissoon S, Frampton GM, Ross JS, Fratella-Calabrese A, Gay L, Ali S, Miller V, Elvin J, Hadigol M, Hirshfield KM, Rodriguez-Rodriguez L, Ganesan S, Khiabanian H.

Blood. 2018 May 31;131(22):2501-2505. doi: 10.1182/blood-2018-03-840629. Epub 2018 Apr 20. No abstract available.


Comprehensive genomic profiling aids in treatment of a metastatic endometrial cancer.

Dhami J, Hirshfield KM, Ganesan S, Hellmann M, Rojas V, Amorosa JK, Riedlinger GM, Zhong H, Ali SM, Pavlick D, Elvin JA, Rodriguez-Rodriguez L.

Cold Spring Harb Mol Case Stud. 2018 Apr 2;4(2). pii: a002089. doi: 10.1101/mcs.a002089. Print 2018 Apr.


Cancer risk and clinicopathological characteristics of thyroid nodules harboring thyroid-stimulating hormone receptor gene mutations.

Mon SY, Riedlinger G, Abbott CE, Seethala R, Ohori NP, Nikiforova MN, Nikiforov YE, Hodak SP.

Diagn Cytopathol. 2018 May;46(5):369-377. doi: 10.1002/dc.23915. Epub 2018 Mar 8.


Immune Activation and Benefit From Avelumab in EBV-Positive Gastric Cancer.

Panda A, Mehnert JM, Hirshfield KM, Riedlinger G, Damare S, Saunders T, Kane M, Sokol L, Stein MN, Poplin E, Rodriguez-Rodriguez L, Silk AW, Aisner J, Chan N, Malhotra J, Frankel M, Kaufman HL, Ali S, Ross JS, White EP, Bhanot G, Ganesan S.

J Natl Cancer Inst. 2018 Mar 1;110(3):316-320. doi: 10.1093/jnci/djx213.


Roadmap to a Comprehensive Clinical Data Warehouse for Precision Medicine Applications in Oncology.

Foran DJ, Chen W, Chu H, Sadimin E, Loh D, Riedlinger G, Goodell LA, Ganesan S, Hirshfield K, Rodriguez L, DiPaola RS.

Cancer Inform. 2017 Mar 2;16:1176935117694349. doi: 10.1177/1176935117694349. eCollection 2017.


Patient-Derived Xenograft Models of Non-Small Cell Lung Cancer and Their Potential Utility in Personalized Medicine.

Morgan KM, Riedlinger GM, Rosenfeld J, Ganesan S, Pine SR.

Front Oncol. 2017 Jan 19;7:2. doi: 10.3389/fonc.2017.00002. eCollection 2017.


Use of comprehensive genomic profiling to direct point-of-care management of patients with gynecologic cancers.

Rodriguez-Rodriguez L, Hirshfield KM, Rojas V, DiPaola RS, Gibbon D, Hellmann M, Isani S, Leiser A, Riedlinger GM, Wagreich A, Ali SM, Elvin JA, Miller VA, Ganesan S.

Gynecol Oncol. 2016 Apr;141(1):2-9. doi: 10.1016/j.ygyno.2016.02.021.


Development of a database system and image viewer to assist in the correlation of histopathologic features and digital image analysis with clinical and molecular genetic information.

Yagi Y, Riedlinger G, Xu X, Nakamura A, Levy B, Iafrate AJ, Mino-Kenudson M, Klepeis VE.

Pathol Int. 2016 Feb;66(2):63-74. doi: 10.1111/pin.12382. Epub 2016 Jan 18.


Environmental components and methods for engaging pathology residents in informatics training.

Garcia CA, Baron JM, Beckwith BA, Brodsky V, Dighe AS, Gudewicz TM, Kim JY, Klepeis VE, Lane WJ, Lee RE, Levy BP, Mahowald MA, Mandelker D, McClintock DS, Quinn AM, Rao LK, Riedlinger GM, Rudolf J, Gilbertson JR.

J Pathol Inform. 2015 Jun 29;6:42. eCollection 2015. No abstract available.


Text mining in cancer gene and pathway prioritization.

Luo Y, Riedlinger G, Szolovits P.

Cancer Inform. 2014 Oct 13;13(Suppl 1):69-79. doi: 10.4137/CIN.S13874. eCollection 2014. Review.


The ongoing evolution of the core curriculum of a clinical fellowship in pathology informatics.

Quinn AM, Klepeis VE, Mandelker DL, Platt MY, Rao LK, Riedlinger G, Baron JM, Brodsky V, Kim JY, Lane W, Lee RE, Levy BP, McClintock DS, Beckwith BA, Kuo FC, Gilbertson JR.

J Pathol Inform. 2014 Jul 30;5(1):22. doi: 10.4103/2153-3539.137717. eCollection 2014.


Pathology informatics fellowship training: Focus on molecular pathology.

Mandelker D, Lee RE, Platt MY, Riedlinger G, Quinn A, Rao LK, Klepeis VE, Mahowald M, Lane WJ, Beckwith BA, Baron JM, McClintock DS, Kuo FC, Lebo MS, Gilbertson JR.

J Pathol Inform. 2014 Mar 28;5(1):11. doi: 10.4103/2153-3539.129444. eCollection 2014.


Aspergillus tanneri sp. nov., a new pathogen that causes invasive disease refractory to antifungal therapy.

Sugui JA, Peterson SW, Clark LP, Nardone G, Folio L, Riedlinger G, Zerbe CS, Shea Y, Henderson CM, Zelazny AM, Holland SM, Kwon-Chung KJ.

J Clin Microbiol. 2012 Oct;50(10):3309-17. doi: 10.1128/JCM.01509-12. Epub 2012 Aug 1.


Outcomes of patients with esophageal cancer staged with [¹⁸F]fluorodeoxyglucose positron emission tomography (FDG-PET): can postchemoradiotherapy FDG-PET predict the utility of resection?

Monjazeb AM, Riedlinger G, Aklilu M, Geisinger KR, Mishra G, Isom S, Clark P, Levine EA, Blackstock AW.

J Clin Oncol. 2010 Nov 1;28(31):4714-21. doi: 10.1200/JCO.2010.30.7702. Epub 2010 Sep 27.


The spectrum of resistance in SR/CR mice: the critical role of chemoattraction in the cancer/leukocyte interaction.

Riedlinger G, Adams J, Stehle JR Jr, Blanks MJ, Sanders AM, Hicks AM, Willingham MC, Cui Z.

BMC Cancer. 2010 May 3;10:179. doi: 10.1186/1471-2407-10-179.


Cancer resistance of SR/CR mice in the genetic knockout backgrounds of leukocyte effector mechanisms: determinations for functional requirements.

Sanders AM, Stehle JR Jr, Blanks MJ, Riedlinger G, Kim-Shapiro JW, Monjazeb AM, Adams JM, Willingham MC, Cui Z.

BMC Cancer. 2010 Mar 31;10:121. doi: 10.1186/1471-2407-10-121.


Impact of sex, MHC, and age of recipients on the therapeutic effect of transferred leukocytes from cancer-resistant SR/CR mice.

Stehle JR Jr, Blanks MJ, Riedlinger G, Kim-Shapiro JW, Sanders AM, Adams JM, Willingham MC, Cui Z.

BMC Cancer. 2009 Sep 15;9:328. doi: 10.1186/1471-2407-9-328.


Transferable anticancer innate immunity in spontaneous regression/complete resistance mice.

Hicks AM, Riedlinger G, Willingham MC, Alexander-Miller MA, Von Kap-Herr C, Pettenati MJ, Sanders AM, Weir HM, Du W, Kim J, Simpson AJ, Old LJ, Cui Z.

Proc Natl Acad Sci U S A. 2006 May 16;103(20):7753-8. Epub 2006 May 8.


Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation.

Cui Y, Riedlinger G, Miyoshi K, Tang W, Li C, Deng CX, Robinson GW, Hennighausen L.

Mol Cell Biol. 2004 Sep;24(18):8037-47.


Tsg101 is essential for cell growth, proliferation, and cell survival of embryonic and adult tissues.

Wagner KU, Krempler A, Qi Y, Park K, Henry MD, Triplett AA, Riedlinger G, Rucker III EB, Hennighausen L.

Mol Cell Biol. 2003 Jan;23(1):150-62.


The aryl hydrocarbon receptor (AhR) and its nuclear translocator (Arnt) are dispensable for normal mammary gland development but are required for fertility.

Le Provost F, Riedlinger G, Hee Yim S, Benedict J, Gonzalez FJ, Flaws J, Hennighausen L.

Genesis. 2002 Mar;32(3):231-9.


Bcl-x is not required for maintenance of follicles and corpus luteum in the postnatal mouse ovary.

Riedlinger G, Okagaki R, Wagner KU, Rucker EB 3rd, Oka T, Miyoshi K, Flaws JA, Hennighausen L.

Biol Reprod. 2002 Feb;66(2):438-44.


Structure of the mouse Stat 3/5 locus: evolution from Drosophila to zebrafish to mouse.

Miyoshi K, Cui Y, Riedlinger G, Robinson P, Lehoczky J, Zon L, Oka T, Dewar K, Hennighausen L.

Genomics. 2001 Jan 15;71(2):150-5.


Conditional deletion of the Bcl-x gene from erythroid cells results in hemolytic anemia and profound splenomegaly.

Wagner KU, Claudio E, Rucker EB 3rd, Riedlinger G, Broussard C, Schwartzberg PL, Siebenlist U, Hennighausen L.

Development. 2000 Nov;127(22):4949-58.


[Non-invasive studies on the cardiac effect of low digitoxin maintenance doses (author's transl)].

Belz GG, Riedlinger G.

Z Kardiol. 1980 Apr;69(4):296-306. German. No abstract available.


Supplemental Content

Loading ...
Support Center